Receptor-mediated basic fibroblast growth factor signaling regulates cyclic pressure-induced human endothelial cell proliferation

Endothelium. 2004 Sep-Dec;11(5-6):285-91. doi: 10.1080/10623320490904205.

Abstract

Vascular endothelial cells sense and respond to pressure by molecular mechanism(s) which, to date, remain poorly understood. The present study investigated basic fibroblast growth factor (bFGF) signaling as a putative mechanotransduction pathway involved in the proliferative responses of human umbilical vein endothelia cells (HUVECs) to 60/20 mm Hg cyclic pressure at 1 Hz for 24 h. Under these conditions, the enhanced proliferative response of these HUVECs was not associated with an increased synthesis/release of bFGF, but involved rapid (within 30 min from the onset of exposure to pressure) tyrosine phosphorylation of the bFGF receptor, FGFR-2. Furthermore, monoclonal antibodies to either bFGF or FGFR-2 attenuated the increased proliferation of HUVECs exposed to 60/20 mm Hg cyclic pressure. HUVECs proliferation under 60/20 mm Hg at 1 Hz cyclic pressure is, therefore, dependent upon bFGF and involves FGFR-2 activation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antibodies, Monoclonal / immunology
  • Cell Division / physiology*
  • Endothelial Cells / cytology
  • Endothelial Cells / physiology*
  • Endothelium, Vascular / physiology
  • Fibroblast Growth Factor 2 / immunology
  • Fibroblast Growth Factor 2 / physiology*
  • Humans
  • Phosphorylation
  • Receptors, Fibroblast Growth Factor / immunology
  • Receptors, Fibroblast Growth Factor / physiology*
  • Signal Transduction / physiology*
  • Tyrosine / metabolism

Substances

  • Antibodies, Monoclonal
  • Receptors, Fibroblast Growth Factor
  • Fibroblast Growth Factor 2
  • Tyrosine